Direct factory supply of absorbable bio-polymers, plant-derived micro-porous starch, chitin powders, and surgical repair materials certified under ISO 13485 and CE standards.
Integrating world-class bio-polymer research, controlled-environment synthesis, and rigorous international quality systems to deliver zero-defect absorbable surgical hemostats worldwide.
Our absorbable starch-based hemostatic powders and cellulose agents undergo rigorous cytotoxicity, sensitization, systemic toxicity, and hemocompatibility testing according to ISO 10993 standards, ensuring absolute safety upon tissue contact.
Synthesis, micronization, sifting, and primary foil packaging are conducted within strict HEPA-filtered cleanrooms, preventing airborne micro-particulate contamination and keeping bacterial endotoxin levels below international pharmacopoeia limits.
We supply complete, audit-ready regulatory dossiers (including STED documentation, clinical evaluation report, risk assessment per ISO 14971, and validated sterilization records) to support rapid registration by international importers.
Eliminating bovine (BSE/TSE) and porcine viral disease transmission risks, our Micro-porous Polysaccharide Spheres (MPH) are derived from pure purified plant starch, offering biocompatible degradation into glucose by endogenous amylase.
The molecular sieve effect rapidly dehydrates blood components, concentrating platelets, thrombin, and fibrinogen at the bleeding site to create a robust, natural physiological clot in under 2 minutes.
Full-scale private label customization ranging from custom powder mesh size (particle distribution), applicator nozzle lengths (laparoscopic delivery), blister tray artwork, to multi-language medical packaging.
Understanding the molecular pathways, absorption kinetics, and tissue interaction profiles of modern absorbable hemostats in operating rooms.
Absorbable Hemostatic Powders engineered from Micro-porous Polysaccharide Spheres (MPH) feature thousands of microscopic porous structures per particle with controlled pore diameters ranging from 10 to 100 microns. Upon contact with whole blood, these hydrophilic spheres rapidly absorb water molecules from serum via capillary forces.
Because cellular blood elements—such as erythrocytes (red blood cells), blood platelets, thrombin, and fibrinogen—exceed the pore size of the spheres, they remain strictly concentrated on the outer surface of the particles. This localized hyper-concentration accelerates the intrinsic clotting cascade, triggering rapid platelet aggregation and forming a dense, gel-like matrix that seals capillary beds, venous oozing, and arterial bleeding sites without relying on exogenous coagulation factors.
The table below illustrates key performance indicators across major commercial surgical hemostatic powder and matrix technologies:
| Hemostatic Powder Type | Active Raw Material | Time to Hemostasis | Complete In-Vivo Resorption | Storage Temperature | Pathogen Risk |
|---|---|---|---|---|---|
| Starch-Based MPH Powder | 100% Plant Polysaccharide | < 90 Seconds | 7 to 14 Days | Ambient (15°C – 30°C) | Zero (Non-Animal) |
| Oxidized Cellulose Powder | Micro-Fibrillar ORC | 2 to 3 Minutes | 14 to 28 Days | Ambient (15°C – 25°C) | Zero (Plant-Derived) |
| Chitosan Micro-Powder | Deacetylated Chitin | < 60 Seconds | 30 to 60 Days | Ambient (5°C – 30°C) | Zero (Shellfish/Fungal) |
| Thrombin Gelatin Matrix | Bovine/Porcine Gelatin + Thrombin | 2 to 4 Minutes | 4 to 6 Weeks | Refrigerated (2°C – 8°C) | Low (Viral Clearance required) |
Bio-resorption speed is critical in avoiding tissue granuloma, chronic foreign body reactions, or surgical site adhesions. Plant starch-derived hemostatic powders break down naturally via endogenous alpha-amylase and glucosidase enzymes into simple glucose oligosaccharides. These metabolites are readily cleared through normal cellular respiration and renal excretion.
Histopathological studies demonstrate complete clearance of starch spheres from liver resection beds, orthopedic cancellous bone surfaces, and gynecological surgical sites within 14 days post-op, leaving no residual scar matrix or fibrous capsule behind.
Insights into shifting market demands, technological evolutions, and regulatory transitions guiding global surgical supply chain strategies.
Detailed answers covering regulatory compliance, sterilization validation, custom private-label MOQ, and technical performance metrics.
Starch-based Micro-porous Polysaccharide Spheres (MPH) act via a mechanical molecular sieve effect, dehydrating blood instantly to concentrate endogenous clotting factors. They resorb completely within 7–14 days through amylase digestion. ORC (Oxidized Regenerated Cellulose) works by lowering local pH to form a dark gelatinous mass that seals vessels, resorbing over 2–4 weeks. While ORC provides natural bactericidal properties due to its low pH, starch powders cause zero tissue inflammation and are ideal when rapid degradation and minimal tissue reaction are required.
Our absorbable starch hemostatic powders undergo validated Ethylene Oxide (EO) sterilization or controlled low-dose Gamma Irradiation, achieving a Sterility Assurance Level (SAL) of 10^-6 in accordance with ISO 11135 and ISO 11137 standards. Primary packaging features medical-grade peelable foil pouches that maintain a sterile barrier against moisture and microbial ingress throughout its 3- to 5-year shelf life.
Yes. As a primary manufacturer, we offer turnkey OEM solutions including custom powder volume filling (e.g., 0.5g, 1.0g, 2.0g, 3.0g, and 5.0g bellows), custom applicator tip dimensions (standard 14cm rigid tips or flexible 38cm endoscopic tips), customized outer carton branding, and multi-language instructions for use (IFU).
We provide full documentation for international medical device registration, including ISO 13485 Quality Management System certificates, CE marks under EU MDR (Regulation 2017/745), ISO 10993 Biocompatibility Test Reports, Endotoxin testing records (< 20 EU/device), Stability Study Reports (accelerated and real-time), and Clinical Evaluation Reports (CER).
Yes. Starch-based MPH powder functions via physical dehydration and physical concentration of cellular blood elements. Because it rapidly extracts fluid and creates a dense physical plug of agglutinated red blood cells and platelets, it remains clinically effective even in patients with systemic anti-coagulation or low clotting factor concentrations.
For our standard factory-branded sterile packages, the MOQ is 500 units per specification, with dispatch within 7–10 business days. For customized OEM private-label production, the typical MOQ is 2,000 units, with a turnaround time of 3 to 4 weeks depending on artwork approval and primary foil print validation.
Upgrade your surgical product portfolio with high-margin, CE & ISO certified absorbable hemostatic powders, chitosan granules, and surgical mesh materials. Contact our technical sales team for sample kits, regulatory dossiers, and wholesale quotation packages.
